investing in Science
that matters
About Us
Portfolio Value as of March 2026
US$ 240m+
Sectors
Healthcare & AI
Scope
Seed to IPO
Find us in
Hong kong
Portfolio companies
Phase Scientific is a Hong Kong-based medical diagnostics company specializing in liquid biopsy technology for urine samples, using its proprietary PHASIFY™ platform to concentrate and detect biomarkers with enhanced precision. The company is pioneering the world's first urine-based cervical cancer screening test, making early cancer detection more accessible and non-invasive.
Insilico Medicine is a globally leading end-to-end generative AI-driven biotech company in terms of AIDD pipeline progress, with a mission to accelerate drug discovery and development by leveraging its rapidly evolving, proprietary Pharma.AI platform across biology, chemistry, and clinical development. Insilico Medicine is listed on the Hong Kong Stock Exchenge (3696.HK)
HiRO
HiRO brings the strength of a global organization together with the agility and insight of regional teams. By linking people, systems, and expertise across continents, we give sponsors a Modern CRO experience — one that adapts to regional challenges while maintaining disciplined, transparent execution everywhere we operate.
Primanova combines the expertise of global leaders in clinical care and medtech development to build a pipeline of products tackling the underserved space of neurosurgery and neurocritical care.
